Document is current
Any future updates will be listed below
-
Authors
Anthamatten, Laura
von Bieberstein, Philipp Rogalla http://orcid.org/0000-0002-1391-3285
Menzi, Carmen http://orcid.org/0000-0002-8656-3183
Zünd, Janina N. http://orcid.org/0009-0008-0687-8822
Lacroix, Christophe http://orcid.org/0000-0003-4360-2020
de Wouters, Tomas http://orcid.org/0000-0002-4592-2338
Leventhal, Gabriel E. http://orcid.org/0000-0002-4463-166X
-
Funding
Funding for this research was provided by:
AVINA Foundation
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 31 July 2024
First Online: 30 September 2024
Declarations
:
: The research project was approved by the Ethic Committee of the Canton of Zurich (2017-01290).
: Not applicable.
: L.A., P.R.v.B., C.M., T.d.W., and G.E.L. are or were employees of PharmaBiome. T.d.W. and C.L. are founders of PharmaBiome. L.A. is a co-founder of PharmaBiome. L.A., P.R.v.B., T.d.W., and G.E.L. are inventors on the patent application WO 2022/023458 A1 entitled “Microbial Niche Mapping” and on the patent application WO 2023/118460 A1 entitled “New biomarker for disorders and diseases associated with intestinal dysbiosis”. PharmaBiome provided financial support.
